CME

CME


Optimizing Treatment Selection and Side Effect Management in BRAF-Mutant Melanoma

November 22, 2021

Host: Jeffrey S. Weber, MD, PhD

Approximately half of metastatic cutaneous melanomas carry mutations in BRAF, leading to more aggressive disease. For patients with BRAF V600–activating mutations, treatment options now include the use of combination t